Divalent Metal-ion Transporter 1 as a Therapeutic Target to Optimize Intestinal Iron Transport
二价金属离子转运蛋白 1 作为优化肠道铁转运的治疗靶点
基本信息
- 批准号:9314563
- 负责人:
- 金额:$ 51.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAnemiaArthritisBindingBiochemicalCardiomyopathiesChronicComplexCopperDataDevelopmentDiabetes MellitusDietary IronDiseaseDuodenumEnterocytesEpitheliumErythropoiesisFatigueFutureGene SilencingGenesGingerGlobinGoalsHemorrhageHereditary hemochromatosisHomeostasisHormonesHumanHypoxiaImmune responseImmunologic TechniquesImpaired cognitionImpairmentImpotenceIndividualInfantInflammationInheritedIntestinesInvestigationIonsIronIron OverloadKnockout MiceLipidsMaintenanceMalignant neoplasm of liverMediatingMediator of activation proteinModalityModelingMolecularMorbidity - disease rateMusMutateMutationNutrientNutritionalOsteoporosisOxidesPathologicPatientsPhysiologicalPlayPost-Translational Protein ProcessingPregnancyProcessProductionPropertyProteinsRat Cell LineRattusRegulationRiskRodent ModelRoleSmall Interfering RNASmall IntestinesStructureSymptomsSystemTechnologyTestingThalassemia intermediaTherapeuticTissuesTransferrinabsorptionbariatric surgerybasebasolateral membranebeta Thalassemiabrush border membraneclinically significantdivalent metalfallshepcidinin vivoinsightiron deficiencyliver injurymRNA Expressionmetal transporting protein 1mortalitymouse modelnanoparticlenovelnovel therapeuticsnutritional approachpre-clinicalpreventprophylacticprotein functionrapid growththerapeutic targetuptakevectoryoung woman
项目摘要
Project Summary
Iron is an essential nutrient for humans, yet excess iron is toxic. As such, iron overload and iron deficiency
result in severe homeostatic perturbations. Iron overload is most frequently associated with hereditary
hemochromatosis (HH), which afflicts ~1:250 adults in the U.S. Tissue iron accumulation in patients with HH
leads to arthritis, osteoporosis, liver damage and cancer, cardiomyopathy, diabetes mellitus, and impotence.
HH results from impaired production of the iron-regulatory hormone hepcidin (HEPC) or as a result of
mutations in the HAMP gene (encoding HEPC). HEPC limits intestinal iron absorption. Moreover, reduced
HEPC synthesis underlies the iron loading that typifies disorders of ineffective erythropoiesis (e.g. β-
thalassemia intermedia [βTI]). In HH and βTI, intestinal iron absorption is thus excessive. This leads to
pathological iron overload since humans cannot excrete excess iron. Regulation of intestinal iron absorption is
thus critical to properly control body iron levels. Dietary iron exists primarily as inorganic (or nonheme) iron.
Ferric (Fe3+) nonheme iron is first reduced to Fe2+, imported into duodenal enterocytes by divalent metal-ion
transporter 1 (DMT1), exported by ferroportin 1 (FPN1) and oxidized for binding to transferrin. DMT1 is the
primary intestinal iron importer under basal conditions, but the relative contribution of DMT1 to iron
accumulation in HH and βTI is unknown. In Aim 1, we will thus test the hypothesis that DMT1 is required
for iron loading in mouse models of HH (HEPC KO) and βTI (Hbbd3th; with a mutated β major globin [Hbb-
b1]) gene. We will thus generate HEPC and Hbb-b1 KO mice that are also lacking intestinal DMT1. We further
hypothesize that decreasing DMT1 expression will prevent iron loading in HH and βTI. Accordingly, we have
developed ginger nanoparticle-derived lipid vectors (GNLVs) which can deliver functional DMT1 siRNA to the
mouse duodenum in vivo (~40% reduction in DMT1 expression). In Aim 2, this GNLV delivery system will be
tested for its ability to prevent iron loading in rodent models of HH and βTI. Furthermore, iron deficiency (ID) is
also common in the U.S., afflicting ~8 million young women, and 700,000 infants. ID frequently occurs when
absorption of dietary iron does not meet the body’s demand. ID most commonly occurs as a consequence of
rapid growth, pregnancy, menstrual blood loss, malabsorptive disorders, gastric bypass surgery and chronic
inflammation. ID symptoms include anemia, impaired cognition, decreased immune response, and fatigue.
During ID, DMT1 increases Cu transport into duodenal enterocytes and emerging data demonstrates that
copper is critical to support iron repletion during states of deficiency. The mechanism that transforms DMT1
into a copper transporter is, however, unknown. Aim 3 will thus test the hypothesis that the DMT1 protein is
post-translationally modified during iron deficiency, allowing Cu transport. Plausible alternative hypotheses
may also be considered. Overall, this DMT1-focused investigation is likely to potentiate the development of
novel therapeutic and nutritional approaches to modulate intestinal iron absorption in at-risk individuals.
项目概要
铁是人体必需的营养素,但过量的铁是有毒的。因此,铁过量和铁缺乏
导致严重的体内平衡紊乱。铁超载最常与遗传有关
血色素沉着病 (HH),影响约 1:250 的美国成年人 HH 患者的组织铁蓄积
导致关节炎、骨质疏松症、肝损伤和癌症、心肌病、糖尿病和阳痿。
HH 是由于铁调节激素铁调素 (HEPC) 的产生受损或由于
HAMP 基因(编码 HEPC)突变。 HEPC 限制肠道铁的吸收。此外,还减少了
HEPC 合成是铁负荷的基础,铁负荷是无效红细胞生成障碍(例如 β-
中间型地中海贫血[βTI])。在 HH 和 βTI 中,肠道铁吸收过多。这导致
病理性铁超载,因为人类无法排出多余的铁。肠道铁吸收的调节是
因此,正确控制体内铁水平至关重要。膳食铁主要以无机(或非血红素)铁的形式存在。
三价铁 (Fe3+) 非血红素铁首先还原为 Fe2+,通过二价金属离子输入十二指肠肠细胞
转运蛋白 1 (DMT1),由铁转运蛋白 1 (FPN1) 输出并被氧化以与转铁蛋白结合。 DMT1 是
基础条件下主要肠道铁输入者,但 DMT1 对铁的相对贡献
HH 和 βTI 中的积累情况未知。在目标 1 中,我们将检验需要 DMT1 的假设
用于 HH (HEPC KO) 和 βTI (Hbbd3th;具有突变 β 主要球蛋白 [Hbb-
b1]) 基因。因此,我们将产生同样缺乏肠道 DMT1 的 HEPC 和 Hbb-b1 KO 小鼠。我们进一步
假设降低 DMT1 表达将阻止 HH 和 βTI 中的铁负荷。据此,我们有
开发了生姜纳米颗粒衍生的脂质载体 (GNLV),该载体可以将功能性 DMT1 siRNA 传递至
小鼠十二指肠体内(DMT1 表达减少约 40%)。在目标 2 中,该 GNLV 传输系统将是
测试了其在 HH 和 βTI 啮齿动物模型中防止铁负荷的能力。此外,缺铁(ID)是
这种疾病在美国也很常见,约 800 万年轻女性和 70 万婴儿受其困扰。 ID 经常出现在以下情况
膳食铁的吸收不能满足人体的需要。 ID 最常发生的原因是
快速生长、怀孕、月经失血、吸收不良、胃绕道手术和慢性
炎。 ID 症状包括贫血、认知受损、免疫反应下降和疲劳。
ID 期间,DMT1 增加铜转运至十二指肠肠细胞,新出现的数据表明
铜对于缺铁状态下补充铁至关重要。转化DMT1的机制
然而,进入铜转运蛋白的情况尚不清楚。因此,目标 3 将检验以下假设:DMT1 蛋白是
缺铁期间发生翻译后修饰,允许铜转运。合理的替代假设
也可以考虑。总体而言,这项以 DMT1 为重点的研究可能会促进
调节高危人群肠道铁吸收的新治疗和营养方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James F. Collins其他文献
<span class="small-caps">dl</span>-2-[3,4-<sup>3</sup>H]Amino-4-phosphonobutyrate binding sites in the rat hippocampus: distribution and possible physiological role
- DOI:
10.1016/0006-8993(87)90596-8 - 发表时间:
1987-09-01 - 期刊:
- 影响因子:
- 作者:
Steven P. Butcher;Peter J. Roberts;James F. Collins - 通讯作者:
James F. Collins
Independence of sensitivity on different foveal areas
- DOI:
10.3758/bf03214129 - 发表时间:
1973-06-01 - 期刊:
- 影响因子:1.700
- 作者:
James F. Collins - 通讯作者:
James F. Collins
ACELL November 46/5
ACELL 十一月 46/5
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
Y. Guner;P. Kiela;XU Hua;James F. Collins;F. Ghishan - 通讯作者:
F. Ghishan
Aminoacyltransferase II from Rat Liver: I. PURIFICATION AND ENZYMATIC PROPERTIES
- DOI:
10.1016/s0021-9258(18)62428-7 - 发表时间:
1971-02-25 - 期刊:
- 影响因子:
- 作者:
Samuel Raeburn;James F. Collins;Hong Mo Moon;Elizabeth S. Maxwell - 通讯作者:
Elizabeth S. Maxwell
Molecular cloning, promoter characterization, and gene structure of murine intestinal type IIB sodium-phosphate cotransporter gene
- DOI:
10.1016/s0016-5085(00)80270-x - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Kayo Arima;James F. Collins;Eric R. Hines;Liqun Bai;Fayez K. Ghishan - 通讯作者:
Fayez K. Ghishan
James F. Collins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James F. Collins', 18)}}的其他基金
Mechanisms of Heme and Non-heme Iron Absorption in Murine Models of Iron Overload
铁过载小鼠模型中血红素和非血红素铁吸收的机制
- 批准号:
10701227 - 财政年份:2022
- 资助金额:
$ 51.35万 - 项目类别:
Divalent Metal-ion Transporter 1 as a Therapeutic Target to Optimize Intestinal Iron Transport
二价金属离子转运蛋白 1 作为优化肠道铁转运的治疗靶点
- 批准号:
9920132 - 财政年份:2016
- 资助金额:
$ 51.35万 - 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron Deficiency
缺铁期间肠道金属离子转运的分子机制
- 批准号:
8506803 - 财政年份:2007
- 资助金额:
$ 51.35万 - 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron Deficiency
缺铁期间肠道金属离子转运的分子机制
- 批准号:
9919534 - 财政年份:2007
- 资助金额:
$ 51.35万 - 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron Deficiency
缺铁期间肠道金属离子转运的分子机制
- 批准号:
8813554 - 财政年份:2007
- 资助金额:
$ 51.35万 - 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-Deficiency
缺铁期间肠道金属离子转运的分子机制
- 批准号:
7706543 - 财政年份:2007
- 资助金额:
$ 51.35万 - 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-Deficiency
缺铁期间肠道金属离子转运的分子机制
- 批准号:
7636746 - 财政年份:2007
- 资助金额:
$ 51.35万 - 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-Deficiency
缺铁期间肠道金属离子转运的分子机制
- 批准号:
7587761 - 财政年份:2007
- 资助金额:
$ 51.35万 - 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-Deficiency
缺铁期间肠道金属离子转运的分子机制
- 批准号:
8098833 - 财政年份:2007
- 资助金额:
$ 51.35万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 51.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 51.35万 - 项目类别:














{{item.name}}会员




